201 KAR 2:220. Collaborative care agreements

Link to law: http://www.lrc.ky.gov/kar/201/002/220.htm
Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
      201 KAR 2:220. Collaborative care



      RELATES TO: KRS 315.010(4), 315.040(4),


      STATUTORY AUTHORITY: KRS 315.191(1)(a)


315.191(1)(a) authorizes the Board of Pharmacy to promulgate administrative

regulations to regulate and control matters relating to pharmacists, pharmacist

interns, pharmacist technicians, pharmacies, wholesale distributors, and

manufacturers. This administrative regulation establishes minimum requirements

for the development and maintenance of collaborative care agreements between an

individual pharmacist and an individual practitioner.


      Section 1. A collaborative care agreement


      (1) Be in writing;

      (2) Be signed and dated by the:

      (a) Individual practitioner;

      (b) Individual pharmacist; and

      (c) Patient or care giver;

      (3) Provide that upon termination of the

agreement the individual practitioner or individual pharmacist shall notify the

patient in writing;

      (4) State the method for termination of

the agreement; and

      (5) Contain the information specified by

Section 2 of this administrative regulation.


      Section 2. A collaborative care agreement

shall contain the following information:

      (1) Patient name;

      (2) Patient address and telephone number;

      (3) Protocol, criteria, standing orders,

or other method by which services are authorized;

      (4) The method established for the

assessment of patient outcomes, if appropriate; and

      (5) Lab tests that may be ordered.


      Section 3. The following information

relating to a collaborative care agreement shall be maintained by a pharmacist

and shall be provided to the collaborating practitioner:

      (1) Emergency notification contact;

      (2) Date of birth, weight, height, and


      (3) Prescription regimen;

      (4) Nonprescription regimen;

      (5) Medical history; including:

      (a) Known diseases;

      (b) Known allergies; and

      (c) Reactions and conditions relating to:

      1. Prescription regimens; and

      2. Nonprescription regimens;

      (6) Lab tests ordered, including results

of lab tests;

      (7) Assessments of patient outcomes;

      (8) Notes relating to contacts between

the individual pharmacist and the individual practitioner concerning the care

and course of therapy of the patient; and

      (9) Documentation of the specific

counseling information provided to the patient or care giver.


      Section 4. A collaborative care

agreement, and information and records required by the provisions of this

administrative regulation, shall be maintained:

      (1) At the pharmacist's practice site;


      (2) For at least five (5) years after

termination. (23

Ky.R. 3125; Am. 3807; 4109; eff. 6-16-97; 34 Ky.R. 2421; eff. 8-1-2008.)